Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions
AlopeciaAlopecia, AndrogeneticBaldness
Interventions
DRUG

bimatoprost Formulation A

bimatoprost Formulation A applied topically to the scalp once daily on Day 1 and Days 4-17.

DRUG

bimatoprost Formulation B

bimatoprost Formulation B applied topically to the scalp once daily on Day 1 and Days 4-17.

DRUG

bimatoprost Formulation C

bimatoprost Formulation C applied topically to the scalp once daily on Day 1 and Days 4-17.

Trial Locations (1)

Unknown

Tempe

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY